Retired Partner
Stuart Kurlander, former Global Co-Chair of the Healthcare & Life Sciences Practice and Global Co-Chair of the Israel Practice, retired from the partnership in June 2023.
Mr. Kurlander has dedicated over three decades to providing strategic counsel to healthcare and life sciences companies doing business or seeking to do business in the United States.
He deftly guides clients through the market access, reimbursement, and commercialization complexities inherent in the US healthcare system, as well as the implications for companies and investors with healthcare and life sciences interests. Mr. Kurlander advises businesses across the health care & life sciences industry, including:
Mr. Kurlander represents healthcare interests at all levels of government through a Washington insider’s lens in matters before the US Department of Health and Human Services Centers for Medicare & Medicaid Services (CMS) and the Office of the Inspector General (OIG), as well as the US Department of Justice.
He distills the technical regulatory concepts that define and underly the US healthcare system and communicates them in practical terms to global private equity funds, investment banks, and venture capital funds amid their highest-stakes transactions. Mr. Kurlander also helps private and public healthcare and life science companies navigate regulatory challenges at every stage of the corporate life cycle.
A recognized leader, Mr. Kurlander founded and built Latham’s leading Healthcare & Life Sciences Practice out of the Washington, D.C., office, expanding the breadth of the firm’s medtech, diagnostic, digital health, biotechnology, and health service offerings over more than a decade as Chair of the D.C. Healthcare & Life Sciences Practice and his years as Global Healthcare & Life Sciences Practice Chair.
Mr. Kurlander established and then co-chaired the Israel Practice, which led to the opening of a Tel Aviv office. He also established the Healthcare & Life Sciences Practice in Israel, which has led to the regulatory and transactional representation of a wide variety of Israel-based businesses.
He began his career as an attorney in the Office of the General Counsel, CMS Division, US Department of Health and Human Services Office, where he drafted Medicare and Medicaid regulations and litigated complex Medicare and Medicaid cases in federal court.
Mr. Kurlander has garnered recognition from top industry authorities, including Chambers USA, The Legal 500 US, LMG Euromoney, and Nightingale’s Healthcare News. He also authors articles and columns in major healthcare publications; speaks nationally on emerging topics; and actively participates in national and international healthcare, legal, civic, and community organizations, including the Cosmos Club in Washington, D.C.
Firm awarded for excellence and innovation in the life science legal space.
Chambers USA recognized the firm’s Mergers & Acquisitions Practice for “world class expertise when it comes to the most challenging transactions.”
Stuart Kurlander honored for his leadership in advancing LGBTQ equality and inclusion in the workplace.